Literature DB >> 8792469

Complement and immune complexes.

M J Walport1, K A Davies.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8792469     DOI： 10.1016/0923-2494(96)87182-3

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  8 in total

Review 1.  Antibodies as carrier proteins.

Authors:  B N Rehlaender; M J Cho
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

2.  Anti-drug antibodies as drug carriers. I. For small molecules.

Authors:  B N Rehlaender; M J Cho
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

3.  Histidine-rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor.

Authors:  N N Gorgani; J G Altin; C R Parish
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

4.  Systemic inflammation in cardiovascular and periodontal disease: comparative study.

Authors:  Ingrid Glurich; Sara Grossi; Boris Albini; Alex Ho; Rashesh Shah; Mohamed Zeid; Heinz Baumann; Robert J Genco; Ernesto De Nardin
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus.

Authors:  Qingjun Pan; Linjie Guo; Jing Wu; Jun Cai; Huanjin Liao; Qiaofen Lan; Yanxia Peng; Yiming He; Hua-Feng Liu
Journal:  Mediators Inflamm       Date:  2016-08-11       Impact factor: 4.711

6.  IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.

Authors:  Qingjun Pan; Haiyan Xiao; Lei Shi; Yiming He; Jun Cai; Jing Wu; Aifen Li; Lin Ye; Chen Yang; Hua-Feng Liu
Journal:  Front Immunol       Date:  2020-06-17       Impact factor: 7.561

Review 7.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09

8.  Complement consumption in children with Plasmodium falciparum malaria.

Authors:  Nancy K Nyakoe; Ronald P Taylor; Joseph N Makumi; John N Waitumbi
Journal:  Malar J       Date:  2009-01-09       Impact factor: 2.979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.